Advocacy intelligence hub — real-time data for patient organizations
Makena: FDA approved
Makena auto-injector for subcutaneous injection is indicated to reduce the risk of preterm birth in women with singleton pregnancy who have a history of singleton spontaneous preterm birth.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Makena
AMAG Pharma USA, Inc.
View all Pancreatic arteriovenous malformation specialists →